Lyra Therapeutics (LYRA) Other Operating Expenses (2022 - 2025)
Historic Other Operating Expenses for Lyra Therapeutics (LYRA) over the last 4 years, with Q2 2025 value amounting to -$2000.0.
- Lyra Therapeutics' Other Operating Expenses fell 10000.81% to -$2000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$21000.0, marking a year-over-year decrease of 10008.5%. This contributed to the annual value of $24.7 million for FY2024, which is 145244.97% up from last year.
- Lyra Therapeutics' Other Operating Expenses amounted to -$2000.0 in Q2 2025, which was down 10000.81% from -$15000.0 recorded in Q1 2025.
- Over the past 5 years, Lyra Therapeutics' Other Operating Expenses peaked at $24.7 million during Q2 2024, and registered a low of -$15000.0 during Q1 2025.
- In the last 4 years, Lyra Therapeutics' Other Operating Expenses had a median value of $657000.0 in 2022 and averaged $4.6 million.
- As far as peak fluctuations go, Lyra Therapeutics' Other Operating Expenses skyrocketed by 145270.1% in 2024, and later plummeted by 10000.81% in 2025.
- Over the past 4 years, Lyra Therapeutics' Other Operating Expenses (Quarter) stood at $1.3 million in 2022, then rose by 20.97% to $1.6 million in 2023, then crashed by 100.25% to -$4000.0 in 2024, then skyrocketed by 50.0% to -$2000.0 in 2025.
- Its Other Operating Expenses was -$2000.0 in Q2 2025, compared to -$15000.0 in Q1 2025 and -$4000.0 in Q4 2024.